Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options DOI Creative Commons
Arturo Cesaro,

Gianantonio De Michele,

Fabio Fimiani

et al.

Frontiers in Cardiovascular Medicine, Journal Year: 2023, Volume and Issue: 10

Published: July 27, 2023

Obesity is a heterogeneous disease that affects almost one-third of the global population. A clear association has been established between obesity and cardiovascular (CVD). However, CVD risk known to be related more local distribution fat than total body fat. Visceral adipose tissue (VAT) in particular high impact on risk. This manuscript reviews role VAT residual CV available therapeutic strategies for decreasing accumulation. Among many pathways involved risk, particularly accumulation play major by generating low-grade systemic inflammation, which turn prognostic all-cause mortality myocardial infarction. In recent years, approaches have developed reduce weight. Orlistat was shown both weight but low tolerability drug-drug interactions. Naltrexone-bupropion combination lowers frequent side effects contraindicated patients with uncontrolled hypertension. Liraglutide semaglutide, glucagon-like peptide 1 (GLP-1) agonists, are latest drugs approved treatment obesity, induce significant loss. Liraglutide, semaglutide other GLP-1 agonists also showed positive effect outcomes diabetic patients. addition, liraglutide specifically inflammatory biomarkers obese without diabetes. promising compounds limit inflammation human visceral adipocytes.

Language: Английский

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study DOI Creative Commons
Frédéric Martino

Intensive Care Medicine, Journal Year: 2020, Volume and Issue: 47(1), P. 60 - 73

Published: Oct. 29, 2020

Language: Английский

Citations

773

Adipose-tissue plasticity in health and disease DOI Creative Commons
Alexander P. Sakers, Mirian Krystel De Siqueira, Patrick Seale

et al.

Cell, Journal Year: 2022, Volume and Issue: 185(3), P. 419 - 446

Published: Feb. 1, 2022

Language: Английский

Citations

526

COVID-19 pandemic: the effects of quarantine on cardiovascular risk DOI Creative Commons
Anna Vittoria Mattioli, Matteo Ballerini Puviani, Milena Nasi

et al.

European Journal of Clinical Nutrition, Journal Year: 2020, Volume and Issue: 74(6), P. 852 - 855

Published: May 5, 2020

COVID-19 is causing a global pandemic with high number of deaths and infected people. To contain the diffusion virus, Governments have enforced restrictions on outdoor activities or even collective quarantine population. One important consequence change in lifestyle: reduced physical activity unhealthy diet. 2019 guidelines for primary prevention cardiovascular disease indicate that "Adults should engage at least 150 minute per week accumulated moderate-intensity 75 vigorous-intensity aerobic (or an equivalent combination moderate vigorous activity) to reduce ASCVD risk." During quarantine, strategies further increase home-based follow healthy diet be implemented. Quarantine carries some long-term effects disease, mainly related lifestyle anxiety. Following action supporting mandatory encourage people return good lifestyle.

Language: Английский

Citations

373

Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019? DOI Open Access
Paul M. Ryan, Noel M. Caplice

Obesity, Journal Year: 2020, Volume and Issue: 28(7), P. 1191 - 1194

Published: April 21, 2020

Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcomes include advanced age, male sex, preexisting cardiovascular disease, and risk factors including hypertension, diabetes, and, recently, obesity. This article posits new obesity-driven of COVID-19 outcomes, over above obvious extant risks associated with obesity, cardiometabolic hypoventilation syndrome intensive care patients. also outlines theoretical mechanistic framework whereby adipose tissue individuals obesity may act as reservoir extensive viral spread, increased shedding, immune activation, cytokine amplification. paper proposes studies test this concept focus on specific pathways that might be amplified COVID-19. Finally, underscores emerging therapeutic strategies benefit subsets patients which amplification is excessive potentially fatal.

Language: Английский

Citations

314

Obesity and the risk of cardiometabolic diseases DOI
Pedro L. Valenzuela, Pedro Carrera‐Bastos, Adrián Castillo‐García

et al.

Nature Reviews Cardiology, Journal Year: 2023, Volume and Issue: 20(7), P. 475 - 494

Published: March 16, 2023

Language: Английский

Citations

219

Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues DOI Open Access

Lowell Dilworth,

Aldeam Facey,

Felix O. Omoruyi

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(14), P. 7644 - 7644

Published: July 16, 2021

Many approaches have been used in the effective management of type 2 diabetes mellitus. A recent paradigm shift has focused on role adipose tissues development and treatment disease. Brown (BAT) white (WAT) are two main types with beige subsets more recently identified. They play key roles communication insulin sensitivity. However, WAT shown to contribute significantly endocrine function. produces hormones cytokines, collectively called adipocytokines, such as leptin adiponectin. These adipocytokines proven vary conditions, metabolic dysfunction, diabetes, or inflammation. The regulation fat storage, energy metabolism, satiety, release all features tissues. As such, they indicators that may provide insights dysfunction can be considered routes for therapeutic considerations. essential vis-a-vis appetite, storage energy, glucose tolerance, release, solidifies tissue pathogenesis mellitus complications associated

Language: Английский

Citations

214

Neuroinflammation in Alzheimer’s Disease DOI Creative Commons
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná

et al.

Biomedicines, Journal Year: 2021, Volume and Issue: 9(5), P. 524 - 524

Published: May 7, 2021

Alzheimer's disease (AD) is a neurodegenerative associated with human aging. Ten percent of individuals over 65 years have AD and its prevalence continues to rise increasing age. There are currently no effective modifying treatments for AD, resulting in increasingly large socioeconomic personal costs. Increasing age an increase low-grade chronic inflammation (inflammaging) that may contribute the process AD. Although exact mechanisms remain unclear, aberrant elevation reactive oxygen nitrogen species (RONS) levels from several endogenous exogenous processes brain not only affect cell signaling, but also trigger cellular senescence, inflammation, pyroptosis. Moreover, compromised immune privilege allows infiltration peripheral cells infectious agents play role. Additionally, meta-inflammation as well gut microbiota dysbiosis drive neuroinflammatory process. Considering inflammatory/immune pathways dysregulated parallel cognitive dysfunction elucidating relationship between central nervous system facilitate development safe therapy We discuss some current ideas on inflammaging appear summarize details few immunomodulatory strategies being developed selectively target detrimental aspects neuroinflammation without affecting defense against pathogens tissue damage.

Language: Английский

Citations

209

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 DOI Creative Commons
Mikiko Watanabe, Damiano Caruso,

Dario Tuccinardi

et al.

Metabolism, Journal Year: 2020, Volume and Issue: 111, P. 154319 - 154319

Published: July 23, 2020

Language: Английский

Citations

201

The Role of Adipokines in Health and Disease DOI Creative Commons
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco

et al.

Biomedicines, Journal Year: 2023, Volume and Issue: 11(5), P. 1290 - 1290

Published: April 27, 2023

Adipokines are cell-signaling proteins secreted by adipose tissue that has been related to a low-grade state of inflammation and different pathologies. The present review aims analyze the role adipokines in health disease order understand important functions effects these cytokines. For this aim, delves into type adipocytes cytokines produced, as well their functions; relations diseases such cardiovascular, atherosclerosis, mental diseases, metabolic disorders, cancer, eating behaviors; finally, microbiota, nutrition, physical activity is discussed. This information would allow for better understanding on body organisms.

Language: Английский

Citations

192

Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation DOI
Francisco López-Jiménez, Wael Almahmeed, Harold Bays

et al.

European Journal of Preventive Cardiology, Journal Year: 2022, Volume and Issue: 29(17), P. 2218 - 2237

Published: Aug. 25, 2022

The ongoing obesity epidemic represents a global public health crisis that contributes to poor outcomes, reduced quality of life, and >2.8 million deaths each year. Obesity is relapsing, progressive, heterogeneous. It considered chronic disease by the World Federation (WOF) condition Heart (WHF). People living with overweight/obesity are at greater risk for cardiovascular (CV) morbidity mortality. Increased adiposity (body fat), particularly visceral/abdominal fat, linked CV (CVD) via multiple direct indirect pathophysiological mechanisms. development CVD driven, in part, obesity-related metabolic, endocrinologic, immunologic, structural, humoral, haemodynamic, functional alterations. complex multifaceted nature these mechanisms can be challenging understand address clinical practice. often have concurrent physical or psychological disorders (multimorbidity) requiring multidisciplinary care pathways polypharmacy. Evidence indicates intentional weight loss (particularly when substantial) lowers among people overweight/obesity. Long-term maintenance require commitment from both individual those responsible their care. This position paper, developed WOF WHF, aims improve understanding links between CVD, key controversies this area evidence relating cardiometabolic outcomes available management options. Finally, an action plan clinicians provides recommendations help identifying addressing risks (recognizing resource support variances countries).

Language: Английский

Citations

176